Key Highlights

Risk & Performance

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

1 of 0 completed trials have results

Key Signals

1 with results

Phase 3

3(75.0%)

Phase 2

1(25.0%)

4Total

Phase 3(3)

Phase 2(1)

Loading network data...

Showing 4 of 4 trials

A Long-term Safety and Efficacy Study of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Subjects With Acne Vulgaris (GEDACNE-LT)

Role: lead

A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5% in Patients With Acne Vulgaris (GEDACNE 2)

Role: lead

A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1)

Role: lead

Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC

Role: lead

All 4 trials loaded